Abstract
Background: Adalimumab is the only approved biological therapy for hidradenitis suppurativa. Several case reports and case series have been published, but some extra evidence would be useful in clinical diary practice.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
